Heart failure & cardiomyopathies

Novel Electrocardiographic Criteria May Render Possible the More Accurate Recognition of Cardiac Amyloidosis

ESC Heart FailPublished Diagnostic accuracy study

Authors' conclusion

The novel ECG criteria [mostly the aVR < 0.5, (I + aVR)/(V1-4) < 0.375] seem at least as reliable in the diagnosis of CA as the best echocardiographic myocardial deformation criteria

Study context

Population
34 patients with confirmed cardiac amyloidosis (CA) (20 transthyretin, 14 AL) and 45 controls with LV hypertrophy on echocardiography (hypertension, valvular AS, hypertrophic cardiomyopathy)34 CA, 45 controls
Comparison
Five novel electrocardiographic (ECG) criteria for CA vs LV hypertrophy controls
Outcome
Diagnostic accuracy of novel ECG criteria for CA

Performance

As reported in the abstract

Diagnostic performance for CA
StrategyAUCSensitivitySpecificityPPVNPVTest accuracy
I < 0.550.892276.5%84.4%78.8%82.6%81%
aVR < 0.50.879482.4%86.7%82.4%86.7%84.8%
(I + aVR) < 0.5750901685.3%80%76.3%87.8%82.3%
(I + aVR)/(V1-4) < 0.3750.882482.4%86.7%82.4%86.7%84.8%
(I + aVR)/I,aVL,V1-6ID < 0.01150.846276.9%87.5%80%85.4%83.3%

AUC

I < 0.550.8922
aVR < 0.50.8794
(I + aVR) < 0.57509016
(I + aVR)/(V1-4) < 0.3750.8824
(I + aVR)/I,aVL,V1-6ID < 0.01150.8462

Sensitivity

I < 0.5576.5%
aVR < 0.582.4%
(I + aVR) < 0.57585.3%
(I + aVR)/(V1-4) < 0.37582.4%
(I + aVR)/I,aVL,V1-6ID < 0.011576.9%

Specificity

I < 0.5584.4%
aVR < 0.586.7%
(I + aVR) < 0.57580%
(I + aVR)/(V1-4) < 0.37586.7%
(I + aVR)/I,aVL,V1-6ID < 0.011587.5%

PPV

I < 0.5578.8%
aVR < 0.582.4%
(I + aVR) < 0.57576.3%
(I + aVR)/(V1-4) < 0.37582.4%
(I + aVR)/I,aVL,V1-6ID < 0.011580%

NPV

I < 0.5582.6%
aVR < 0.586.7%
(I + aVR) < 0.57587.8%
(I + aVR)/(V1-4) < 0.37586.7%
(I + aVR)/I,aVL,V1-6ID < 0.011585.4%

Test accuracy

I < 0.5581%
aVR < 0.584.8%
(I + aVR) < 0.57582.3%
(I + aVR)/(V1-4) < 0.37584.8%
(I + aVR)/I,aVL,V1-6ID < 0.011583.3%

Further findings

Classical criterion: low voltage in limb leads

Present in CA
73.5%
Test accuracy
78.5%
Sensitivity
73.5%
Specificity
82.2%
PPV
75.8%
NPV
80.4%
  • Slightly worse diagnostic value than the novel ECG criteria

Original publication

Novel Electrocardiographic Criteria May Render Possible the More Accurate Recognition of Cardiac Amyloidosis. ESC Heart Fail. Published 19 January 2024. doi:10.1002/ehf2.14655

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.